A Phase 4 interventional study of ENALAPRIL VALSARTAN METHYLPREDNISONE in IGA Nephropathy, sponsored by Hospital Britanico. Completed at 1 site in Argentina. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2006-11-01.
Sponsored by Hospital Britanico · Phase 4, Interventional, and Treatment
Among 19 studies in Glomerulonephritis, IGA with a site in Argentina — 6 open to participants now, 12 under way, 10 of them phase 3. Glomerulonephritis, IGA · Argentina.
Among the 19 studies in Glomerulonephritis, IGA with a site in Argentina, this one is the 18th largest by enrollment, is the only one that started in 1996, is the only one in phase 4, and was the 1st registered.
275 studies on the registry are indexed under Glomerulonephritis, IGA; 107 are open to participants now.
This study's enrollment of 20 is below the median of 62 across 221 interventional studies indexed under Glomerulonephritis, IGA.
Browse Glomerulonephritis, IGA studies →6 of the 19 studies in Glomerulonephritis, IGA with a site in Argentina are open now, in 12 countries. Each count lists the studies.
Of the 67 Glomerulonephritis, IGA studies recruiting now, 39 (58%) set no upper age limit and 23 (34%) stop at 75 or younger; 20 take children under 18; 5 take healthy volunteers.
This study: 21 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →19 studies; the count open now beside each. This study's row is marked.
First in 1996; this study’s year is marked. 1 started in 1996.
Median enrollment 365 across the 19 interventional studies. Of the 7 that completed or were terminated, 6 (86%) have results posted.
18 of 19 have an industry lead sponsor. The 8 most frequent:
Hospital Britanico is the lead sponsor of 3 studies on the registry; none are open to participants now.
Hospital Britanico has 1 study filed under Glomerulonephritis, IGA — fewer than ten, so there is no comparison to draw.
3 of the studies in Glomerulonephritis, IGA with a site in Argentina that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06935357Phase 3BiogenA Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) | 2027-05-31 |
| NCT05852938Phase 3Novartis PharmaceuticalsA Study of Zigakibart in Adults With IgA Nephropathy | 2027-08-10 |
| NCT06797518Novartis PharmaceuticalsStudy to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN | 2027-11-27 |
Among the 19 studies in Glomerulonephritis, IGA with a site in Argentina, from their registry updates:
TO ASSESS THE EFFICACY OF THE RENIN ANGIOTENSIN SYSTEM PLUS STEROIDS TO DECREASE THE AMOUNT OF PROTEINURIA IN IGA NEPHROPATHY
Patients whose proteinuria was > 0.5 g/day were to receive enalapril plus valsartan coupled with oral 0.5 g/day of methylprednisone for 6 months.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DAILY PROTEINURIA
RENAL FUNCTION AS ASSESSED BY SERUM CREATININE
The record gives a start of Jan 1996 and a completion of Dec 2005. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 1996. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Britanico